Evidence map›Paper›PMID 30656511›Full record

ArticleInternational ophthalmology2019

First experience with Oasis Collagen SOFT SHIELD

Ivo Guber, Ciara Bergin, Shruti Malde, Josef Guber, Samer Hamada, Damian Lake

Abstract readLetter
PubMed Publisher
In one paragraph

Article in International ophthalmology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Ivo GuberQueen Victoria Hospital, NHS Foundation Trust, East Grinstead, West Sussex, UK. ivo.guber@augenchirurgie.ch.ORCID http://orcid.org/0000-0002-5125-8840
Ciara BerginJules-Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland.
Shruti MaldeQueen Victoria Hospital, NHS Foundation Trust, East Grinstead, West Sussex, UK.
Josef GuberDepartment of Ophthalmology, University of Basel, Basel, Switzerland.
Samer HamadaQueen Victoria Hospital, NHS Foundation Trust, East Grinstead, West Sussex, UK.
Damian LakeQueen Victoria Hospital, NHS Foundation Trust, East Grinstead, West Sussex, UK.
Queen Victoria Hospital NHS Foundation Trust · GBUniversity of Basel · CHUniversity of Geneva · CHUniversity of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo investigate response of dissolving collagen contact lenses as an alternative for bandage contact lenses, for the post-interventional care of epithelial defects after corneal cross-linking (CXL) treatment for keratoconus. PATIENTS AND

methodsFollow-up visits were performed at day 1, 4 and 1 month after the intervention. We reviewed notes for re-epithelialization, comfort/pain and any untoward effects of Collagen SOFT SHIELD

resultsThirty consecutive CXL patients with collagen shield application after CXL were included. Mean age was 28 years (range from 16 to 51 years old). Pre-CXL VA was 0.7 logMAR IQR 0.4-1.0; post-CXL VA at day 4 and month 1 was 0.6 logMAR IQR 0.4-0.9. Post-operative mean SE was 5.5D ± 4.1D. In all patients, the Collagen SOFT SHIELD

conclusionsThis study indicates that Oasis Collagen SOFT SHIELD

Indexed as

Contact Lenses, HydrophilicAdolescentAdultCollagenCross-Linking ReagentsFemaleHumansKeratoconusMaleMiddle AgedPhotochemotherapyPhotosensitizing AgentsVisual AcuityYoung AdultCollagenCross-Linking ReagentsPhotosensitizing AgentsBandage contact lensCollagen soft shieldCorneal collagen cross-linkingCorneal epithelial defectCorneal re-epithelialization

Identifiers

PMID30656511
OpenAlexW2910148919

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.